Cargando…
Association between a single nucleotide polymorphism in the R3HCC1 gene and irinotecan toxicity
OBJECTIVE: Irinotecan is a useful anticancer drug for colorectal cancer treatment. UGT1A1*28 and *6 gene polymorphisms are known risk factors for irinotecan‐associated toxicity. However, severe adverse effects due to irinotecan have been observed even in patients who do not harbor UGT1A1*28 or *6. W...
Autores principales: | Kanesada, Kou, Tsunedomi, Ryouichi, Hazama, Shoichi, Ogihara, Hiroyuki, Hamamoto, Yoshihiko, Shindo, Yoshitaro, Matsui, Hiroto, Tokumitsu, Yukio, Yoshida, Shin, Iida, Michihisa, Suzuki, Nobuaki, Takeda, Shigeru, Ioka, Tatsuya, Nagano, Hiroaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972014/ https://www.ncbi.nlm.nih.gov/pubmed/36308049 http://dx.doi.org/10.1002/cam4.5299 |
Ejemplares similares
-
CD4 and FOXP3 as predictive markers for the recurrence of T3/T4a stage II colorectal cancer: applying a novel discrete Bayes decision rule
por: Nakagami, Yuki, et al.
Publicado: (2022) -
Pancreatic Cancer Stem-Like Cells With High Calreticulin Expression Associated With Immune Surveillance
por: Fujiwara, Yasuhiro, et al.
Publicado: (2021) -
Elevated expression of RAB3B plays important roles in chemoresistance and metastatic potential of hepatoma cells
por: Tsunedomi, Ryouichi, et al.
Publicado: (2022) -
A novel prediction model of pancreatic fistula after pancreaticoduodenectomy using only preoperative markers
por: Matsui, Hiroto, et al.
Publicado: (2023) -
Novel Biomarkers for Personalized Cancer Immunotherapy
por: Shindo, Yoshitaro, et al.
Publicado: (2019)